Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of the Effect of Two Doses of Mometasone Furoate Dry Powder Inhaler 200 mcg and 400 mcg QD PM, Fluticasone Propionate 250 mcg BID, and Montelukast 10 mg QD PM, on Bone Mineral Density in Adults With Asthma

NCT00394355 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00394355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00394355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of the Effect of Two Doses of Mometasone Furoate Dry Powder Inhaler 200 mcg and 400 mcg QD PM, Fluticasone Propionate 250 mcg BID, and Montelukast 10 mg QD PM, on Bone Mineral Density in Adults With Asthma
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
October 31, 2009
Enrollment
566 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma